Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a simple pill replace IV drips for blood infections?

NCT ID NCT05199324

First seen Apr 17, 2026

Summary

This study tests whether stable patients with a common blood infection (gram-negative bacteraemia) can safely switch from IV antibiotics to oral pills within 72 hours. Researchers will compare early oral therapy to continued IV treatment in 720 adults. The main goal is to see if survival rates at 30 days are similar between the two groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRAM-NEGATIVE BACTERAEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tan Tock Seng Hospital

    RECRUITING

    Singapore, Singapore, 308433, Singapore

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Oral fluoroquinolones (e.g., ciprofloxacin) or oral trimethoprim-sulfamethoxazole (Bactrim)

What this could lead to

If successful, this could show that switching to oral antibiotics early is as safe and effective as staying on IV therapy, potentially reducing hospital stays and treatment costs.

What could go wrong

This is a single-center trial, and results may not apply to all patients. The oral antibiotics may not work as well in sicker patients or those with hidden infection sources.

Conditions

The condition(s) this trial relates to.

bacterial infectious disease with sepsis gram-negative bacterial infections

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.